S&P 500   4,350.02 (+0.46%)
DOW   34,111.68 (+0.12%)
QQQ   360.77 (+0.81%)
AAPL   175.69 (+1.01%)
MSFT   320.05 (+0.16%)
META   304.90 (+3.10%)
GOOGL   131.78 (+1.03%)
AMZN   131.25 (+1.48%)
TSLA   254.40 (-0.51%)
NVDA   417.05 (+1.68%)
NIO   8.65 (+2.37%)
BABA   88.61 (+5.35%)
AMD   97.74 (+1.70%)
T   15.16 (-0.98%)
F   12.63 (+3.52%)
MU   69.22 (+1.94%)
CGC   0.85 (+10.14%)
GE   113.12 (+0.12%)
DIS   82.47 (-0.31%)
AMC   7.87 (+2.21%)
PFE   32.57 (-0.85%)
PYPL   58.97 (+0.60%)
NFLX   383.88 (-0.07%)
S&P 500   4,350.02 (+0.46%)
DOW   34,111.68 (+0.12%)
QQQ   360.77 (+0.81%)
AAPL   175.69 (+1.01%)
MSFT   320.05 (+0.16%)
META   304.90 (+3.10%)
GOOGL   131.78 (+1.03%)
AMZN   131.25 (+1.48%)
TSLA   254.40 (-0.51%)
NVDA   417.05 (+1.68%)
NIO   8.65 (+2.37%)
BABA   88.61 (+5.35%)
AMD   97.74 (+1.70%)
T   15.16 (-0.98%)
F   12.63 (+3.52%)
MU   69.22 (+1.94%)
CGC   0.85 (+10.14%)
GE   113.12 (+0.12%)
DIS   82.47 (-0.31%)
AMC   7.87 (+2.21%)
PFE   32.57 (-0.85%)
PYPL   58.97 (+0.60%)
NFLX   383.88 (-0.07%)
S&P 500   4,350.02 (+0.46%)
DOW   34,111.68 (+0.12%)
QQQ   360.77 (+0.81%)
AAPL   175.69 (+1.01%)
MSFT   320.05 (+0.16%)
META   304.90 (+3.10%)
GOOGL   131.78 (+1.03%)
AMZN   131.25 (+1.48%)
TSLA   254.40 (-0.51%)
NVDA   417.05 (+1.68%)
NIO   8.65 (+2.37%)
BABA   88.61 (+5.35%)
AMD   97.74 (+1.70%)
T   15.16 (-0.98%)
F   12.63 (+3.52%)
MU   69.22 (+1.94%)
CGC   0.85 (+10.14%)
GE   113.12 (+0.12%)
DIS   82.47 (-0.31%)
AMC   7.87 (+2.21%)
PFE   32.57 (-0.85%)
PYPL   58.97 (+0.60%)
NFLX   383.88 (-0.07%)
S&P 500   4,350.02 (+0.46%)
DOW   34,111.68 (+0.12%)
QQQ   360.77 (+0.81%)
AAPL   175.69 (+1.01%)
MSFT   320.05 (+0.16%)
META   304.90 (+3.10%)
GOOGL   131.78 (+1.03%)
AMZN   131.25 (+1.48%)
TSLA   254.40 (-0.51%)
NVDA   417.05 (+1.68%)
NIO   8.65 (+2.37%)
BABA   88.61 (+5.35%)
AMD   97.74 (+1.70%)
T   15.16 (-0.98%)
F   12.63 (+3.52%)
MU   69.22 (+1.94%)
CGC   0.85 (+10.14%)
GE   113.12 (+0.12%)
DIS   82.47 (-0.31%)
AMC   7.87 (+2.21%)
PFE   32.57 (-0.85%)
PYPL   58.97 (+0.60%)
NFLX   383.88 (-0.07%)
NYSE:BTX

Brooklyn ImmunoTherapeutics (BTX) Stock Forecast, Price & News

$2.08
+0.02 (+0.97%)
(As of 09/21/2023 ET)
Compare
Today's Range
$2.00
$2.18
50-Day Range
$2.05
$2.96
52-Week Range
$0.17
$10.10
Volume
4,443 shs
Average Volume
515,543 shs
Market Capitalization
$122.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BTX stock logo

About Brooklyn ImmunoTherapeutics (NYSE:BTX) Stock

Eterna Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.

BTX Price History

BTX Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Brooklyn Hospital Center
Brooklyn Technical High School
Brooklyn Preparatory High School
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Brooklyn ImmunoTherapeutics Announces Board Changes
See More Headlines
Receive BTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brooklyn ImmunoTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Television Broadcasting
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$122.36 million
Optionable
Optionable
Beta
4.61
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Matthew Angel
    President, Chief Executive Officer & Director
  • Andrew C. Jackson
    Chief Financial Officer
  • Roger Sidhu
    Chief Medical Officer
  • Jay Sial
    Chief Administrative Officer
  • Sandra Gurrola
    Principal Accounting Officer & VP-Finance













BTX Stock - Frequently Asked Questions

How have BTX shares performed in 2023?

Brooklyn ImmunoTherapeutics' stock was trading at $3.22 on January 1st, 2023. Since then, BTX shares have decreased by 35.4% and is now trading at $2.08.
View the best growth stocks for 2023 here
.

What is Brooklyn ImmunoTherapeutics' stock symbol?

Brooklyn ImmunoTherapeutics trades on the New York Stock Exchange (NYSE) under the ticker symbol "BTX."

How do I buy shares of Brooklyn ImmunoTherapeutics?

Shares of BTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Brooklyn ImmunoTherapeutics' stock price today?

One share of BTX stock can currently be purchased for approximately $2.08.

How much money does Brooklyn ImmunoTherapeutics make?

Brooklyn ImmunoTherapeutics (NYSE:BTX) has a market capitalization of $122.36 million.

How can I contact Brooklyn ImmunoTherapeutics?

The company can be reached via phone at (212) 582-1199.

This page (NYSE:BTX) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -